The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics

Jardine Meg J. and Mahaffey Kenneth W. and Neal Bruce and Agarwal Rajiv and Bakris George L. and Brenner Barry M. and Kollaborációs szervezet: CREDENCE study investigators and Csecsei Gyöngyi and Csiky Botond and Danos Péter and Deák László and Dudás Mihály and Keltai Katalin and Takács Róbert and Rosivall László and et al. (kollab. közrem.): The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics.
AMERICAN JOURNAL OF NEPHROLOGY, 46 (6). pp. 462-472. ISSN 0250-8095 (2017)

[thumbnail of Jardine.pdf]
Preview
Text
Jardine.pdf - Published Version

Download (361kB) | Preview
Item Type: Journal Article
Journal or Publication Title: AMERICAN JOURNAL OF NEPHROLOGY
Date: 2017
Volume: 46
Number: 6
Page Range: pp. 462-472
ISSN: 0250-8095
Faculty/Unit: Not SZTE unit
Institution: Más intézmény
Language: English
MTMT rekordazonosító: 30322892
DOI azonosító: https://doi.org/10.1159/000484633
Date Deposited: 2023. Mar. 03. 08:41
Last Modified: 2023. Mar. 03. 08:41
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/26666
Web of Science® Times Cited: 178 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year